Triazolo-pyrimidine analogs for treatment of diseases associated with wia syndrome RECQ helicase (WRN) inhibition
The present invention provides compounds having formula (I): wherein R1, R2, R3, R4, R5, R26, R27, y, R, M, W, L, V, T, Y, J, K and A are as described herein, or pharmaceutically acceptable salts thereof, therapeutic uses of the compounds, uses of the compounds as research type chemicals, pharmaceut...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention provides compounds having formula (I): wherein R1, R2, R3, R4, R5, R26, R27, y, R, M, W, L, V, T, Y, J, K and A are as described herein, or pharmaceutically acceptable salts thereof, therapeutic uses of the compounds, uses of the compounds as research type chemicals, pharmaceutical compositions and combinations comprising the compounds, and processes for making compounds of the invention. # imgabs0 #
本发明提供了具有式(I)的化合物或其药学上可接受的盐:其中R1、R2、R3、R4、R5、R26、R27、y、R、M、W、L、V、T、Y、J、K和A如本文所述,还提供了所述化合物的治疗用途、所述化合物作为研究型化学物质的用途、包含所述化合物的药物组合物和组合、以及用于制造本发明的化合物的方法。#imgabs0# |
---|